+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Radiopharmaceutical Theranostics"

Radiopharmaceutical Theranostics Market Report 2025 - Product Thumbnail Image

Radiopharmaceutical Theranostics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Radiopharmaceutical Theranostics is a field of Nuclear Medicine and Radiopharmacology that focuses on the development of radiopharmaceuticals for the diagnosis and treatment of diseases. Radiopharmaceuticals are drugs that contain radioactive isotopes and are used to diagnose and treat diseases such as cancer, heart disease, and neurological disorders. Theranostics is a combination of the words “therapy” and “diagnostics” and refers to the use of radiopharmaceuticals for both diagnosis and treatment. Radiopharmaceutical Theranostics is a rapidly growing field, with new developments in imaging technology and radiopharmaceuticals allowing for more accurate diagnosis and treatment of diseases. Some companies in the Radiopharmaceutical Theranostics market include GE Healthcare, Siemens Healthineers, Mallinckrodt Pharmaceuticals, and Bracco Diagnostics. Show Less Read more